Literature DB >> 35829903

Potential Bioactive Compounds from Marine Streptomyces sp. and Their In Vitro Antibiofilm and Antibacterial Activities Against Antimicrobial-Resistant Clinical Pathogens.

Ranjithkumar Dhandapani1,2, Sathiamoorthi Thangavelu3, Latha Ragunathan4, Ragul Paramasivam2, Palanivel Velmurugan5, Saravanan Muthupandian6.   

Abstract

Antimicrobial resistance issues have risen dramatically in recent years, posing a severe concern to humans worldwide. The urgent need to find novel compounds for pharmaceutical applications prompts the research of under-explored environments such as marine ecosystems. The present study was designed to discover novel secondary metabolites, and we have isolated about 30 actinomycetes from the marine soil samples collected in Thondi (Ramanathapuram, Tamil Nadu, India), where most isolates are associated with the genus Streptomyces. Out of 30, one potentially active strain (Streptomyces sp. SRMA3) was identified using primary and secondary screening methods against the drug-resistant clinical pathogens. The active metabolites extracted from the selected active isolate were subjected to partial purification and characterization using Fourier transform infrared spectrophotometer (FTIR) and gas chromatography-mass spectroscopy (GC-MS) analysis. The minimum inhibitory concentration (MIC) value was determined for the active metabolite. Further, the partially purified active fraction was revealed for its antibacterial and antibiofilm activity against drug-resistant clinical pathogens. Light and fluorescence microscopy detected the viability and adhesion of the biofilm-forming drug-resistant pathogens. Growth curve analysis showed that the active metabolite has the potential to inhibit drug-resistant pathogens. The synergistic effect of active metabolite with commercial antibiotics also revealed that it could enhance the activity of antibiotics in antimicrobial resistance pathogens. This study shows that the isolated Streptomyces sp. SRMA3 is a potentially active strain, and the metabolite derived from this strain has a good antibacterial and antibiofilm activity against antimicrobially resistant clinical pathogens and could be used for various biotechnological applications.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibacterial; Antibiofilm; Antimicrobial resistance; GC-MS; Streptomyces

Mesh:

Substances:

Year:  2022        PMID: 35829903     DOI: 10.1007/s12010-022-04072-7

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   3.094


  21 in total

Review 1.  Marine-derived fungi: a chemically and biologically diverse group of microorganisms.

Authors:  Tim S Bugni; Chris M Ireland
Journal:  Nat Prod Rep       Date:  2004-01-09       Impact factor: 13.423

2.  Streptomyces associated with a marine sponge Haliclona sp.; biosynthetic genes for secondary metabolites and products.

Authors:  Shams Tabrez Khan; Hisayuki Komaki; Keiichiro Motohashi; Ikuko Kozone; Akira Mukai; Motoki Takagi; Kazuo Shin-ya
Journal:  Environ Microbiol       Date:  2010-09-16       Impact factor: 5.491

Review 3.  Ecology of actinomycetes.

Authors:  M Goodfellow; S T Williams
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

4.  Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria.

Authors:  Petros I Rafailidis; Diamantis Kofteridis
Journal:  Expert Rev Anti Infect Ther       Date:  2021-07-14       Impact factor: 5.091

Review 5.  Renewed interests in the discovery of bioactive actinomycete metabolites driven by emerging technologies.

Authors:  Jenifer Ossai; Behnam Khatabi; S Eric Nybo; Madan K Kharel
Journal:  J Appl Microbiol       Date:  2021-07-29       Impact factor: 3.772

Review 6.  Antibiotics: past, present and future.

Authors:  Matthew I Hutchings; Andrew W Truman; Barrie Wilkinson
Journal:  Curr Opin Microbiol       Date:  2019-11-13       Impact factor: 7.584

7.  Isolation, Screening, and Identification of Novel Isolates of Actinomycetes from India for Antimicrobial Applications.

Authors:  Vineeta Singh; Shafiul Haque; Harshita Singh; Jyoti Verma; Kumari Vibha; Rajbir Singh; Arshad Jawed; C K M Tripathi
Journal:  Front Microbiol       Date:  2016-12-06       Impact factor: 5.640

Review 8.  Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies.

Authors:  Alessia Catalano; Domenico Iacopetta; Jessica Ceramella; Domenica Scumaci; Federica Giuzio; Carmela Saturnino; Stefano Aquaro; Camillo Rosano; Maria Stefania Sinicropi
Journal:  Molecules       Date:  2022-01-18       Impact factor: 4.411

Review 9.  Clinical Perspective of Antimicrobial Resistance in Bacteria.

Authors:  Ying Zhu; Wei E Huang; Qiwen Yang
Journal:  Infect Drug Resist       Date:  2022-03-02       Impact factor: 4.003

10.  Streptomyces sp. 1S1 isolated from Southern coast of the Red Sea as a renewable natural resource of several bioactive compounds.

Authors:  Azal A Mothana; Hassan A Al-Shamahy; Ramzi A Mothana; Jamal M Khaled; Adnan J Al-Rehaily; Abdullah Y Al-Mahdi; Ulrike Lindequist
Journal:  Saudi Pharm J       Date:  2021-12-31       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.